1. Home
  2. CHRO vs GDHG Comparison

CHRO vs GDHG Comparison

Compare CHRO & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • GDHG
  • Stock Information
  • Founded
  • CHRO 2002
  • GDHG 2008
  • Country
  • CHRO United States
  • GDHG China
  • Employees
  • CHRO N/A
  • GDHG N/A
  • Industry
  • CHRO
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • CHRO
  • GDHG Consumer Discretionary
  • Exchange
  • CHRO Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • CHRO 10.7M
  • GDHG 9.0M
  • IPO Year
  • CHRO 2024
  • GDHG 2023
  • Fundamental
  • Price
  • CHRO $1.45
  • GDHG $0.50
  • Analyst Decision
  • CHRO Strong Buy
  • GDHG
  • Analyst Count
  • CHRO 1
  • GDHG 0
  • Target Price
  • CHRO N/A
  • GDHG N/A
  • AVG Volume (30 Days)
  • CHRO 8.2K
  • GDHG 4.5M
  • Earning Date
  • CHRO 03-27-2025
  • GDHG 04-08-2025
  • Dividend Yield
  • CHRO N/A
  • GDHG N/A
  • EPS Growth
  • CHRO N/A
  • GDHG N/A
  • EPS
  • CHRO N/A
  • GDHG N/A
  • Revenue
  • CHRO N/A
  • GDHG $22,333,251.00
  • Revenue This Year
  • CHRO N/A
  • GDHG N/A
  • Revenue Next Year
  • CHRO N/A
  • GDHG N/A
  • P/E Ratio
  • CHRO N/A
  • GDHG N/A
  • Revenue Growth
  • CHRO N/A
  • GDHG N/A
  • 52 Week Low
  • CHRO $0.45
  • GDHG $0.39
  • 52 Week High
  • CHRO $3.80
  • GDHG $22.75
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 43.38
  • GDHG 37.98
  • Support Level
  • CHRO $1.34
  • GDHG $0.72
  • Resistance Level
  • CHRO $2.00
  • GDHG $5.25
  • Average True Range (ATR)
  • CHRO 0.17
  • GDHG 0.91
  • MACD
  • CHRO -0.02
  • GDHG -0.07
  • Stochastic Oscillator
  • CHRO 16.58
  • GDHG 2.34

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: